16441 results
-
List item
Human medicine European public assessment report (EPAR): Clopidogrel 1A Pharma
clopidogrel, Peripheral Vascular Diseases
Date of authorisation: 28/07/2009,
, Revision: 1, Withdrawn, Last updated: 28/02/2011
Clopidogrel 1A Pharma Peripheral Vascular Diseases … Clopidogrel 1A Pharma … to the same company, Acino Pharma GmbH, and they all contain … -
List item
Human medicine European public assessment report (EPAR): Clopidogrel Acino Pharma
clopidogrel, Peripheral Vascular Diseases; Stroke; Myocardial Infarction
Date of authorisation: 21/09/2009,, Revision: 1, Withdrawn, Last updated: 26/07/2012
Clopidogrel Acino Pharma Peripheral Vascular Diseases Stroke Myocardial … Clopidogrel Acino Pharma … statement Clopidogrel Acino Pharma (clopidogrel) Withdrawal … -
List item
Human medicine European public assessment report (EPAR): Lamivudine Teva Pharma B.V.
lamivudine, HIV Infections
Date of authorisation: 10/12/2009,, Revision: 19, Authorised, Last updated: 21/04/2023
Lamivudine Teva Pharma B.V. Blood-Borne Infections Communicable … Lamivudine Teva Pharma B.V … market exclusivity under pharmaceutical legislation (typically 10 … -
List item
Human medicine European public assessment report (EPAR): Pioglitazone Teva Pharma
pioglitazone hydrochloride, Diabetes Mellitus, Type 2
Date of authorisation: 26/03/2012,, Revision: 13, Withdrawn, Last updated: 30/08/2022
Pioglitazone Teva Pharma Nutritional and Metabolic … Pioglitazone Teva Pharma … market exclusivity under pharmaceutical legislation (typically 10 … -
List item
Human medicine European public assessment report (EPAR): Ribavirin Teva Pharma B.V.
Ribavirin, Hepatitis C, Chronic
Date of authorisation: 01/07/2009,, Revision: 14, Withdrawn, Last updated: 09/07/2021
Ribavirin Teva Pharma B.V. Hepatitis C, Chronic … Ribavirin Teva Pharma B.V … Ribavirin Teva and Ribavirin Teva Pharma B.V.) some of the studies … -
List item
Human medicine European public assessment report (EPAR): Clopidogrel Acino Pharma GmbH
clopidogrel, Peripheral Vascular Diseases; Stroke; Myocardial Infarction
Date of authorisation: 21/09/2009,, Revision: 1, Withdrawn, Last updated: 26/07/2012
Clopidogrel Acino Pharma GmbH Peripheral Vascular … Clopidogrel Acino Pharma GmbH … Clopidogrel Acino Pharma GmbH Public Statement … -
List item
Human medicine European public assessment report (EPAR): Clopidogrel Taw Pharma (previously Clopidogrel Mylan)
clopidogrel hydrochloride, Peripheral Vascular Diseases; Stroke; Myocardial Infarction; Acute Coronary Syndrome
Date of authorisation: 21/09/2009,, Revision: 20, Authorised, Last updated: 01/07/2022
Clopidogrel Taw Pharma (previously Clopidogrel Mylan) Vascular … Clopidogrel Taw Pharma is a medicine used to prevent … attack). Clopidogrel Taw Pharma can be started between a … -
List item
Human medicine European public assessment report (EPAR): Kinzalmono (previously Telmisartan Boehringer Ingelheim Pharma KG)
Telmisartan, Hypertension
Date of authorisation: 16/12/1998, Revision: 30, Authorised, Last updated: 18/12/2020Telmisartan Boehringer Ingelheim Pharma KG) Cardiovascular Diseases Vascular … Telmisartan Boehringer Ingelheim Pharma KG … Telmisartan Boehringer Ingelheim Pharma KG) telmisartan Telmisartan … -
List item
Human medicine European public assessment report (EPAR): Clopidogrel Teva Pharma (previously Clopidogrel HCS)
clopidogrel (as hydrochloride), Myocardial Infarction; Peripheral Vascular Diseases; Stroke
Date of authorisation: 21/09/2009,, Revision: 9, Withdrawn, Last updated: 24/10/2017
Clopidogrel Teva Pharma (previously Clopidogrel HCS) Myocardial … Clopidogrel Teva Pharma (previously Clopidogrel HCS … statement Clopidogrel Teva Pharma Withdrawal of the marketing … -
List item
Human medicine European public assessment report (EPAR): Clopidogrel Teva Pharma B.V.
clopidogrel (as hydrobromide), Peripheral Vascular Diseases; Acute Coronary Syndrome; Myocardial Infarction; Stroke
Date of authorisation: 16/06/2011,, Revision: 4, Withdrawn, Last updated: 03/02/2015
Clopidogrel Teva Pharma B.V. Peripheral Vascular … Clopidogrel Teva Pharma B.V … Clopidogrel Teva Pharma B.V. withdrawal of the marketing … -
List item
Human medicine European public assessment report (EPAR): Zoledronic acid Teva Pharma
zoledronic acid, Osteoporosis; Osteitis Deformans; Osteoporosis, Postmenopausal
Date of authorisation: 15/08/2012,, Revision: 11, Withdrawn, Last updated: 12/12/2018
Zoledronic acid Teva Pharma Osteoporosis Osteitis Deformans Osteoporosis … for Zoledronic acid Teva Pharma has been withdrawn at the … documents Zoledronic acid Teva Pharma : EPAR - Summary for the … -
List item
Human medicine European public assessment report (EPAR): Tenecteplase Boehringer Ingelheim Pharma GmbH Co. KG
tenecteplase, Myocardial Infarction
Date of authorisation: 23/02/2001, Revision: 2, Withdrawn, Last updated: 05/12/2005teplase Boehringer Ingelheim Pharma GmbH Co. KG Myocardial … teplase Boehringer Ingelheim Pharma GmbH Co. KG … TENECTEPLASE BOEHRINGER INGELHEIM PHARMA GmbH & Co. KG (tenecteplase … -
List item
Human medicine European public assessment report (EPAR): Budesonide/Formoterol Teva Pharma B.V.
Budesonide, formoterol fumarate dihydrate, Asthma; Pulmonary Disease, Chronic Obstructive
Date of authorisation: 03/04/2020, Revision: 2, Authorised, Last updated: 08/12/2021Budesonide/Formoterol Teva Pharma B.V. Lung Diseases, Obstructive Lung … Budesonide/Formoterol Teva Pharma B.V., see the package leaflet … or contact your doctor or pharmacist. How does Budesonide/Formoterol … -
List item
Human medicine European public assessment report (EPAR): Budesonide/Formoterol Teva Pharma B.V.
Budesonide, formoterol, Asthma
Date of authorisation: 19/11/2014, Revision: 1, Withdrawn, Last updated: 30/01/2017Budesonide/Formoterol Teva Pharma B.V. Asthma … Budesonide/Formoterol Teva Pharma B.V … Budesonide/Formoterol Teva Pharma B.V. Withdrawal of the marketing … -
List item
National expert: Everaldo Attard, Medicines Authority (updated)
- Declaration of interests - 39.21 KB | PDF
- Curriculum Vitae - 63.64 KB | PDF
Everaldo Attard … Everaldo Attard … Vitae Personal information Everaldo Attard Work experience … -
List item
News: EMA: working for every patient in Europe
Last updated: 08/08/2018EMA: working for every patient in Europe … medicines before they arrive in pharmacies or hospitals and monitors … -
List item
National expert: Marie Pauline J. Evers, European Medicines Agency (updated)
- Declaration of interests - 41.22 KB | PDF
- Curriculum Vitae - 23.96 KB | PDF
Marie Pauline J. Evers … Marie Pauline J. Evers … information Marie Pauline J. Evers Work experience … -
List item
Everolimus product-specific bioequivalence guidance
Last updated: 03/01/2017Everolimus product-specific bioequivalence … of the bioequivalence of everolimus. … Everolimus - Overview of comments received …
-
List item
Workshop on methods for efficacy studies in everyday medical practice
European Medicines Agency, London, UK, from 24/10/2013 to 25/10/2013, Last updated: 24/10/2013methods for efficacy studies in everyday medical practice … methods for efficacy studies in everyday medical practice … for efficacy studies in the everyday practice” 9 December … -
List item
News: First ever guidance for stem cell therapies in animals published
CVMP, Last updated: 23/06/2017First ever guidance for stem cell therapies … approved today the first ever guidance at European Union … described in the European Pharmacopoeia (e.g. 2.6.1 ‘Sterility’ … -
List item
News: European Antibiotic Awareness Day 2013: 'Everyone is responsible'
Last updated: 18/11/2013Antibiotic Awareness Day 2013: 'Everyone is responsible' … theme of this year's EAAD is 'Everyone is responsible'. The European … -
List item
Referral: Renin-angiotensin-system (RAS)-acting agents
captopril, imidapril, zofenopril, candesartan, delapril, telmisartan, aliskiren, moexipril, enalapril, valsartan, fosinopril, irbesartan, perindopril, quinapril, ramipril, eprosartan, olmesartan, trandolapril, losartan, azilsartan, lisinopril, spirapril, benazepril, cilazapril, associated names: Tolucombi, Telmisartan Teva, Telmisartan Teva Pharma, Tolura, Onduarp, Twynsta, Actelsar HCT, Kinzalkomb, MicardisPlus, PritorPlus, Copalia HCT, Dafiro HCT, Exforge HCT, Rasilamlo, Rasilez, Rasilez HCT, Rasitrio, Edarbi, Ipreziv, Aprovel, Ifirmasta (previously Irbesartan Krka), Irbesartan Teva, Irbesartan Zentiva (previously Irbesartan Winthrop), Karvea, Sabervel, CoAprovel, Ifirmacombi, Irbesartan/Hydrochlorothiazide Teva, Irbesartan Hydrochlorothiazide Zentiva (previously Irbesartan Hydrochlorothiazide Winthrop), Karvezide, Kinzalmono (previously Telmisartan Boehringer Ingelheim Pharma KG), Micardis, Pritor, Telmisartan Actavis, Article 31 referrals
Status: European Commission final decision, opinion/position date: 22/05/2014, EC decision date: 04/09/2014, Last updated: 08/10/2014recommendations made by the Agency’s Pharmacovigilance Risk Assessment Committee … artan Teva Telmisartan Teva Pharma Tolura Onduarp Twynsta Actelsar … Telmisartan Boehringer Ingelheim Pharma KG) Micardis Pritor Telmisartan … -
List item
News: European Immunization Week 2023: Statement by Executive Director Emer Cooke - Routine vaccination matters! Every dose counts to stay protected
Last updated: 24/04/2023Routine vaccination matters! Every dose counts to stay protected … is key. I want to remind everyone that vaccines have been used … conversation with your doctor, pharmacist or nurse about immunization … -
List item
Clinical pharmacology and pharmacokinetics: questions and answers
Last updated: 16/12/2022Clinical pharmacology and pharmacokinetics: questions and answers … be well justified.” Most pharmaceutical companies currently use a … with media replenishment every 24 hrs. The mRNA responses …
-
List item
Human medicine European public assessment report (EPAR): Sugammadex Mylan
sugammadex sodium, Neuromuscular Blockade
Date of authorisation: 15/11/2021,, Revision: 2, Authorised, Last updated: 21/06/2023
Uses Physiological Effects of Drugs Pharmacologic Actions Neuromuscular Blocka … Mylan, see the The leaflet in every pack of medicine that contains … or contact your doctor or pharmacist. How does Sugammadex Mylan …